Madrigal Pharmaceuticals, Inc. (MDGL) vs Bio-Techne Corporation (TECH)
A side-by-side comparison of Madrigal Pharmaceuticals, Inc. and Bio-Techne Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDGL
Madrigal Pharmaceuticals, Inc.
$495.65HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
TECH
Bio-Techne Corporation
$72.45HealthcareDelayed quote: Oct 6, 2026, 3:30 PM EDT
Total return — MDGL vs TECH
growth of $100 · dividends reinvested · last 10yMDGL +2930.2% (+40.7%/yr)TECH +183.5% (+11.0%/yr)MDGL compounded faster over this window
Log scale — wide-divergence pair
MDGL TECH
MDGL vs TECH: by the numbers
- •MDGL is the larger company ($11.45B vs $11.34B market cap).
- •TECH is profitable (14.97% net margin) while MDGL runs a net loss (-25.32%).
- •TECH pays a dividend (0.55% yield), while MDGL has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | MDGL | TECH |
|---|---|---|
| P/E ratio | N/A | 62.45 |
| Forward P/E | N/A | 35.42 |
| PEG ratio | N/A | 10.55 |
| P/S ratio | 8.92 | 9.34 |
| P/B ratio | 21.87 | 5.38 |
| EV / EBITDA | N/A | 32.55 |
| FCF yield | N/A | 2.32% |
Profitability
| Metric | MDGL | TECH |
|---|---|---|
| Gross margin | 91.48% | 65.77% |
| Operating margin | -25.13% | 20.73% |
| Net margin | -25.32% | 14.97% |
| ROE | -62.07% | 8.63% |
| ROIC | -37.02% | 7.86% |
Dividends
| Metric | MDGL | TECH |
|---|---|---|
| Dividend yield | N/A | 0.55% |
| Payout ratio | N/A | 34.48% |
Growth (annualized)
| Metric | MDGL | TECH |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.47% |
| EPS CAGR (5Y) | N/A | 5.16% |
| FCF CAGR (5Y) | N/A | -3.08% |
| Total return CAGR (5Y) | 44.41% | -9.26% |
Frequently asked
- Does MDGL or TECH pay a bigger dividend?
- TECH pays a dividend (0.55% yield), while MDGL has no payments in the available dividend history.
- Is MDGL or TECH more profitable?
- TECH runs the higher net margin — MDGL at -25.32% versus TECH at 14.97%.
- How have MDGL and TECH total returns compared?
- Over the past 10 years, MDGL delivered 41.50% and TECH delivered 10.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Techne P/E ratioBio-Techne dividend yieldMadrigal Pharmaceuticals ROEBio-Techne ROEMadrigal Pharmaceuticals operating marginBio-Techne operating marginMadrigal Pharmaceuticals revenue growthBio-Techne revenue growthMadrigal Pharmaceuticals free cash flowBio-Techne free cash flow
Madrigal Pharmaceuticals & Bio-Techne appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.